Wave Bye Inc.

DENVER, CO · Founded 2023 · CIK 0002032246 · Biotech · Private

Non-hormonal oral supplements and medications for PMS and menstrual symptom relief

wavebye.co →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$852K
2 Form D · Apr 2026
6 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$52,000
Private capital raisedForm D · SEC$800,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2765NANOVALENT PHARMACEUTICALS INC——
2766Florey Biosciences, Inc.—$1.4M
2767JSK THERAPEUTICS INC.—$963K
2768Wave Bye Inc.—$852K
2769DIAVACS, INC.—$850K
2770OCEANYX PHARMACEUTICALS, INC.——
2771Niche Biopharmaceuticals LLC—$525K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Margo HarrisonDirector · Executive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.